Exhibitors

Exhibitors for 2024

Situated in the Education Hall. The BCS Exhibition is an integral part of the conference, providing delegates with the opportunity to converse with industry experts about development and research in cardiovascular products and innovation.

We thank our sponsors and exhibitors for their support.

Download the Conference Exhibiting & Symposia Prospectus

AliveCor

AliveCor is transforming heart care by delivering intelligent, personalised heart data to clinicians and patients anytime, anywhere. AliveCor’s clinically validated ECG devices can detect up to 6 of the most common arrhythmias in 30 seconds.

Stand no: 42

Website: www.alivecor.co.uk

Amarin UK

Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our scientific research foundation to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly, committed to reducing cardiovascular risk and making a meaningful impact on patients’ lives.

Stand no:  20

Website: www.amarincorp.co.uk

Amgen 

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Stand no: 16

Website: www.amgen.co.uk

Amicus Therapeutics UK

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high quality medicines for people living with rare metabolic diseases. We are delighted to attend BCS 2024 and you can find us at stand 32.

We would also like to invite you to our symposium 'Finding Fabry: When to suspect a rare cause of cardiomyopathy?' on Monday 3rd June 12:40-13:40 in the Charter 2 auditorium (Amicus products will be discussed). It's a chance to learn about cardiomyopathy in Fabry disease and to hear expert opinion on the impact you can have on patients’ testing and diagnosis. For more information about Fabry Disease, visit us at stand 32, or go to www.amicuseducation.co.uk.

NP-NN-GB-00070524 | May 2024

Stand no: 32

Website: www.amicusrx.co.uk

AstraZeneca UK

Stand no: 6

Website: www.astrazeneca.co.uk

Bristol Myers Squibb

Our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are focused on helping millions of patients globally in disease areas such as oncology, haematology, cardiology, immunology, fibrosis, and specialty medicines.

Stand no: 45

Website: www.bms.com/gb

Boehringer Ingelheim and Lilly Alliance

The Boehringer Ingelheim and Lilly Alliance leverages the strengths of two of the world's leading pharmaceutical companies. By joining forces, the companies demonstrate their commitment to people with type 2 diabetes and addressing areas of unmet medical need such as heart failure and chronic kidney disease.

Stand no: 2

Website: www.boehringer-ingelheim.com

British Heart Foundation

British Heart Foundation (BHF) funds around £100 million annually into cardiovascular research across the UK. From enabling scientific entrepreneurs to translate their discoveries into real-world health benefits, to awarding NHS consultants to become our scientists of the future. Visit stand 8 to speak to the team and discover more.

Stand no: 8

Website: www.bhf.org.uk

British Society for Heart Failure

The BSH is committed to reducing the number of heart failure deaths by 25% over the next 25 years. This would mean 5 fewer deaths for every 100 patients newly diagnosed with heart failure every year, saving 10,000 lives annually. Come to our stand to find out more!

Stand no: CS5

Website: www.bsh.org.uk

British Society of Echocardiography

Stand no: CS6

Website:  www.bsecho.org

Dendrite Clinical Systems UK

Dendrite is a specialist provider of clinical registries, databases and workflow systems for cardiology and other specialties. We can provide a suite of ‘off-the-shelve’ flexible NICOR-compliant databases including CathLab/ACS, MINAP, EP, devices, HF, cardiac rehab, TAVI etc. System design is customisable for each hospital, the system can also be integrated with the local hospital information system (such as EPR/PAS) and can streamline data submission to NICOR.

Dendrite also provides national web-registries and databases multi-site studies. The system can also collect data (PROMs/PREMs) directly from patients.

Stand no: 36

Website: www.e-dendrite.com

European Society of Cardiology

The ESC is a world leader in the discovery and dissemination of best practices in cardiovascular medicine. A volunteer-led, not-for-profit medical society. Our members and decision-makers are scientists, clinicians, nurses and allied professionals working in all fields of cardiology.

Stand no: 28

Website: www.escardio.org

MDDUS

Established in 1902, MDDUS is a not-for-profit mutual defence organisation offering expert advice, assistance and indemnity cover to doctors, dentists, and other healthcare professionals across the UK. Founded by and for healthcare professionals, our mission is to protect and support healthcare professionals and organisations through our advisory and legal services.

Stand no: 30

Website: www.mddus.com

Meril UK Limited

Founded in 2006, Meril is an India based global medical device company. We design, manufacture and distribute clinically relevant, state-of-the-art and best-in-class medical devices to alleviate human suffering.

Stand no: 7

Website: www.merillife.com

Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of healthcare products, including innovative medicines and vaccines.

PP-UNP-GBR-8880 Date of prep: April 2024

Stand no: 15

Website: www.pfizer.co.uk

Women in Cardiology

Women in Cardiology aims to increase the number of women training, working and leading in Cardiology. We aim to champion change, address gender inequality in working practice and support our community of women cardiologists across the UK. We do this via engaging, collaborating, supporting, informing and networking. Please come and visit our stand for more information, and to find out how you can get involved, all welcome.

Stand no: 34

Website: www.womenincardiology.uk